Browse Category

Stocks News 5 December 2025 - 6 December 2025

Moderna (MRNA) Stock: French Study Sparks Rally After FDA Shock – Latest News, Analyst Forecasts and 2026 Outlook

Moderna (MRNA) Stock: French Study Sparks Rally After FDA Shock – Latest News, Analyst Forecasts and 2026 Outlook

Updated: December 6, 2025 Moderna, Inc. (NASDAQ: MRNA) has just had one of its most dramatic weeks of 2025. Shares plunged early in the week after news that the U.S. Food and Drug Administration (FDA) may tighten vaccine approval standards, then rebounded sharply on Friday after a massive French real‑world study reaffirmed the safety and effectiveness of its COVID‑19 vaccine. Investopedia+2Investopedia+2 As of the close on Friday, December 5, Moderna stock finished at $27.70, up 8.7% on the day and trading near the middle of its 52‑week range of $22.28 to $48.92, giving the company a market capitalization of about
Bonds vs Stocks in 2025: Where to Invest as Interest Rates Peak and Markets Rally

Bonds vs Stocks in 2025: Where to Invest as Interest Rates Peak and Markets Rally

As 2025 draws to a close, investors are facing a rare moment: both stocks and bonds have had a strong year, and major central banks are preparing to cut interest rates after one of the sharpest tightening cycles in decades. That makes the classic question — bonds vs stocks — feel more urgent than it has in years. U.S. stocks are up by the mid‑ to high‑teens in 2025, with the S&P 500 boosted by strong tech earnings and resilient consumer demand. Business Insider Global stocks, measured by the MSCI ACWI index, have delivered more than 23% year‑to‑date through the
Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna, Inc. (NASDAQ: MRNA) closed today as one of the more talked‑about healthcare names on Wall Street, with the stock rebounding sharply after a bruising year of falling COVID-19 vaccine sales, pipeline setbacks, and rising regulatory risk. Today’s move comes as investors digest a huge, real‑world French study supporting the long‑term safety and effectiveness of mRNA COVID vaccines, fresh details of a $1.5 billion loan deal, and updated guidance pointing to a slow path back toward growth and eventual profitability. The Chronicle-Journal+1 Below is a deep dive into where Moderna stock stands right now, what’s driving today’s rally, and how
Netflix Stock (NFLX) on December 5, 2025: Warner Bros. Megadeal, 10-for‑1 Split and Fresh Analyst Forecasts

Netflix Stock (NFLX) on December 5, 2025: Warner Bros. Megadeal, 10-for‑1 Split and Fresh Analyst Forecasts

Netflix stock is having one of its most consequential trading days in years. On December 5, 2025, shares of Netflix, Inc. (NASDAQ: NFLX) traded around $100–101, down roughly 2.8% on very heavy volume after the company confirmed an $82.7 billion deal to acquire Warner Bros. and its streaming assets.StockAnalysis At the same time, the stock is still digesting a 10‑for‑1 split that took effect on November 17, 2025, lowering the share price from over $1,000 to roughly $110 per share.Netflix IR+2AInvest+2 Below is a deep dive into today’s news, what it means for Netflix stock, and how Wall Street is
Philip Morris International (PM) Stock: Price Today, Ferrari Deal, 2025 EPS Guidance and Analyst Forecasts (December 5, 2025)

Philip Morris International (PM) Stock: Price Today, Ferrari Deal, 2025 EPS Guidance and Analyst Forecasts (December 5, 2025)

Philip Morris International Inc. (NYSE: PM) is ending the first week of December on a cautious note. After a sharp pullback on Thursday, the stock is trading around $148 per share on December 5, 2025, roughly 20% below its 52‑week high of $186.69 but still up strongly year‑to‑date. MarketWatch+1 At the same time, the company has just reaffirmed double‑digit earnings growth for 2025, announced a renewed multi‑year partnership with Ferrari that puts its ZYN nicotine pouch brand on Formula 1 cars, and continues to lean hard into its smoke‑free transformation powered by IQOS and ZYN. Reuters+4Stock Titan+4Stock Titan+4 This article
Trilogy Metals (TMQ) Stock: U.S. Stake, Ambler Road and 2026 Outlook

Trilogy Metals (TMQ) Stock: U.S. Stake, Ambler Road and 2026 Outlook

As of December 5, 2025 Trilogy Metals Inc. (NYSE American: TMQ; TSX: TMQ) has gone from thinly traded copper explorer to one of the most closely watched critical‑minerals plays in North America. A proposed 211‑mile road into Alaska’s Ambler Mining District, a planned 10% equity stake from the U.S. government, and an aggressive capital‑raising toolkit have transformed both the story and the stock in 2025. Trilogy Metals Inc.+1 Below is a structured look at the latest news, stock performance, forecasts and key risks as of December 5, 2025. TMQ stock snapshot on December 5, 2025 According to real‑time market data,
Johnson & Johnson (JNJ) Stock: Price, Latest News, Analyst Forecasts and Dividend Outlook – December 5, 2025

Johnson & Johnson (JNJ) Stock: Price, Latest News, Analyst Forecasts and Dividend Outlook – December 5, 2025

Johnson & Johnson (NYSE: JNJ) stock has surged in 2025 and is now trading close to record highs, while Wall Street remains broadly positive but increasingly divided on just how much upside is left from here. As of December 5, 2025, investors are digesting a fresh analyst upgrade, a wave of institutional buying, and robust earnings – all against a backdrop of ongoing litigation and a major planned spinoff. Below is a structured look at Johnson & Johnson’s latest stock price, news, forecasts and fundamental drivers as of December 5, 2025. Key Takeaways This article is for informational purposes only
Bank of America Stock (BAC) Near 52-Week High: Latest News, Dividend and 2026 Outlook

Bank of America Stock (BAC) Near 52-Week High: Latest News, Dividend and 2026 Outlook

As of Friday, December 5, 2025, Bank of America Corporation (NYSE: BAC) is trading around $54.21 per share, just below a new 52‑week high of $54.69 set on December 4.MarketBeat Year to date, the stock is up roughly 23%, outpacing many U.S. bank peers and drawing intense interest from both Wall Street and retail investors.Yahoo Finance A wave of fresh news since December 4–5 — spanning crypto access, macro forecasts, options activity, and institutional moves — is now shaping the conversation around BAC’s 2026 prospects. Below is a detailed, SEO‑focused roundup of Bank of America stock news, forecasts, and analysis
Oklo (OKLO) Stock on December 5, 2025: AI‑Fueled Nuclear Bet Faces $1.5B Dilution and Mixed Forecasts

Oklo (OKLO) Stock on December 5, 2025: AI‑Fueled Nuclear Bet Faces $1.5B Dilution and Mixed Forecasts

Oklo Inc. (NYSE: OKLO) has become one of 2025’s wildest stories on Wall Street – a pre‑revenue nuclear start‑up whose stock has soared several hundred percent as artificial intelligence (AI) data centers scramble for new power sources. On December 5, 2025, the narrative is more complicated: Nvidia CEO Jensen Huang just helped ignite another rally with bullish remarks about small nuclear reactors, yet Oklo shares are now under pressure after the company announced plans to sell up to $1.5 billion in new stock, triggering fresh dilution fears. The Economic Times+1 Below is a detailed look at where Oklo stock stands
Palantir (PLTR) Stock Today: Wedbush’s ‘Golden Path’, New AI Deals and the Trillion‑Dollar Debate – December 5, 2025

Palantir (PLTR) Stock Today: Wedbush’s ‘Golden Path’, New AI Deals and the Trillion‑Dollar Debate – December 5, 2025

Updated: December 5, 2025 Palantir Technologies Inc. (NASDAQ: PLTR) is back in the spotlight today as its stock trades around $178 per share, leaving the company valued at more than $420 billion after a blistering AI‑driven run in 2025.MarketBeat Fresh bullish commentary from Wedbush, new AI partnerships and product launches, and a wave of institutional filings are colliding with growing warnings about an AI bubble and Palantir’s extreme valuation. The result: PLTR remains one of the market’s most hotly debated AI stocks heading into 2026.Seeking Alpha+2Trefis+2 Below is a detailed look at today’s key headlines (December 5, 2025), Palantir’s latest
Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies, Inc. (NASDAQ: QCLS) has suddenly gone from obscure microcap to social‑media star. Over just two trading sessions, the stock has effectively doubled after former pharma executive Martin Shkreli disclosed a position, floated a near‑term $100 price target, and hinted at wanting to run the company if regulators ever let him back into a C‑suite. Benzinga+2Stocktwits+2 Underneath the drama is a tiny company that recently pivoted from biotech into “quantum‑class” photonic computing and blockchain infrastructure, built around licensed light‑based processors from Israeli startup LightSolver. Streamlined+3Business Wire+3Business Wire+3 This article pulls together the latest news, price action, forecasts and analyses
New Fortress Energy (NFE) Stock: Puerto Rico Gas Deal Triggers Relief Rally Amid Going‑Concern Fears – December 5, 2025

New Fortress Energy (NFE) Stock: Puerto Rico Gas Deal Triggers Relief Rally Amid Going‑Concern Fears – December 5, 2025

As of December 5, 2025, New Fortress Energy Inc. (NASDAQ: NFE) sits at the center of one of the most dramatic turnarounds‑or‑bust stories in the global LNG market. The stock has bounced on news of a long‑awaited gas supply deal with Puerto Rico, even as the company warns there is “substantial doubt” about its ability to continue as a going concern and scrambles to restructure more than $7–9 billion of debt. Business Wire+2Stock Titan+2 For investors following NFE on Google News or Discover, the picture is a mix of powerful catalysts and very real solvency risk. Where New Fortress Energy
1 66 67 68 69 70 102

Stock Market Today

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

7 February 2026
Nebius shares jumped 16.6% to $86.10 on Friday, rebounding from a 10.3% drop Thursday. The company will report fourth-quarter and full-year 2025 results before the market opens on Feb. 12. U.S. jobs and inflation data are due next week after a delay from a government shutdown. Recent swings in Nebius stock followed volatility in AI-linked tech names after Alphabet’s spending update.
Go toTop